- Dosage: Paracetamol 500mg, Diphenhydramine 5mg, Chlorphenamine 2mg
- Packaging: 10tablets/blister*10/box
- Shelf Life: 36months
Package:
Product Description
Paracetamol Diphenhydramine Chlorphenamine Tablets: What the Published Guidance Says
The three non-opioid analgesics named on the WHO Model List — paracetamol, ibuprofen and acetylsalicylic acid — in the full range of oral, rectal and injectable presentations, plus the wider NSAID family.
This page collects the supply-relevant facts for Paracetamol Diphenhydramine Chlorphenamine Tablets — specification, testing, packaging and the registration paperwork that travels with the batch.
- Paracetamol is an antipyretic and analgesic — not an anti-inflammatory The Model List carries a footnote stating paracetamol is not recommended for anti-inflammatory use due to lack of proven benefit to that effect. Marketing copy that positions paracetamol as an anti-inflammatory is inconsistent with the WHO listing. WHO Model List of Essential Medicines, 24th List (2025) — report of the 25th WHO Expert Committee (TRS 1064)
- Fever control is part of severe-disease management MSF guidance on severe malaria directs paracetamol in the event of high fever only — a reminder that in febrile illness the antipyretic is supportive care, not the disease treatment. MSF Medical Guidelines — Malaria (Chapter 4.3, Parasitic infections)
- A strength-confusion warning that matters commercially The Model List itself warns that the presence of both 120 mg/5 mL and 125 mg/5 mL paracetamol oral liquid strengths on the same market would cause confusion in prescribing and dispensing and should be avoided. Country programmes should therefore settle on one strength. WHO Model List of Essential Medicines, 24th List (2025) — report of the 25th WHO Expert Committee (TRS 1064)
Each point above is reproduced because it has a practical consequence for Paracetamol Diphenhydramine Chlorphenamine Tablets: the strength you can register, the pack you can release, or the wording permitted on the label. Your national prescribing information always takes precedence.
Ordering Parameters for Paracetamol Diphenhydramine Chlorphenamine Tablets
| Product Name | Paracetamol + Diphenhydramine + Chlorphenamine Tablets (Paracetamol 500mg + Diphenhydramine 5mg + Chlorphenamine 2mg Oral Tablets) |
| Specification | Each tablet contains: Paracetamol 500mg + Diphenhydramine Hydrochloride 5mg + Chlorphenamine Maleate 2mg |
| Dosage Form | Oral Film-Coated Tablet (for oral administration) |
| Active Ingredients | Paracetamol / Diphenhydramine Hydrochloride / Chlorphenamine Maleate |
| Pharmacological Class | Analgesic / Antipyretic + Sedating Antihistamine Combination (Cold & Flu / Nighttime Relief) |
| Route of Administration | Oral administration (swallowed whole with water). For bedtime or nighttime use. Do not drive or operate machinery after taking. |
| Storage | Store below 25°C, in a dry place, protected from light and moisture. Keep container tightly closed. Do not freeze. |
| Therapeutic group | Analgesics & NSAIDs — Analgesics & NSAIDs |
| Manufacturer | Sinophare Bio-technology Co., Ltd. (GMP, China) |
| Documentation supplied | COA, HPLC/GC data, stability data, dossier package |
The same therapeutic range is supplied in several presentations, so one purchase order can cover a mixed requirement: Aspirin 300mg Tablets, Ibuprofen 100mg Tablets, Methamizole 500mg Tablets, Paracetamol 500mg Tablets, Paracetamol Effervescent 500mg Tablets, Ibuprofen Suppository 50mg, Indomethacin Suppository 100mg, Naproxen Suppositories 250mg.
Pharmacopoeial Standard, Release Testing & COA
Products are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and full finished-product testing.
Release testing for Paracetamol Diphenhydramine Chlorphenamine Tablets follows the monograph you nominate — USP, EP, BP or CP. If the presentation is not covered by a monograph, the specification is frozen in writing with your quality team before the batch is manufactured.
Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.
The quality control package for the marketed pack covers:
- Testing for microbial limits and preservative efficacy (multi-dose presentations)
- Testing for heavy metals and elemental impurities
- Testing for packaging integrity and seal testing
- Testing for description and identification
- Testing for assay of the active substance
- Testing for related substances and impurities
COA, HPLC and GC data, DMF and dossier packages, plus registration support documents for national marketing-authorisation filings.
Packing, Labelling Languages & Export Paperwork
- Pack size: Blister pack (PVC-Alu) or HDPE bottle, typically 10 or 20 tablets per blister strip, or 100 tablets per bottle. Non-standard pack sizes can be quoted against your artwork.
- Storage: Store below 25°C, in a dry place, protected from light and moisture. Keep container tightly closed. Do not freeze..
- Shelf life: 36 months (unopened). Stability data for the marketed pack is included in the dossier.
- Labelling: we typeset the carton and leaflet in English, Arabic, French, Russian and Spanish and in any further language your market requires, carrying your own brand where the local rules allow.
- Export: commercial invoice, packing list, certificate of origin, GMP certificate, COA and the free-sale certificate issued by the country of manufacture whenever your customs or regulator asks for it.
Marketing Authorisation & Tender Support
The legal manufacturer named on every document for Paracetamol Diphenhydramine Chlorphenamine Tablets is Sinophare Bio-technology Co., Ltd., DML Number Jin20160068 (medicines) and Jin20160069 (paracetamol API).. The same entity appears on the GMP certificate and on the dossier submitted to your regulator.
- Re-test or renewal support when the marketing authorisation comes up for variation or renewal.
- CTD dossier modules 1–5 in editable and PDF form, with the finished-product and API sections cross-referenced.
- Site Master File and GMP certificate for the manufacturing workshops.
- Method validation, stability protocol and the shelf-life justification for the marketed pack.
- Answers to authority questions during assessment, handled by the regulatory contact who prepared the file.
Paracetamol Diphenhydramine Chlorphenamine Tablets is presented here against non-opioid analgesics and NSAIDs named in the WHO Model List. Inclusion in an essential-medicines list does not authorise sale in any particular country — the marketing authorisation for that market is a separate step.
Paracetamol Diphenhydramine Chlorphenamine Tablets: Common Procurement Questions
What pack size is available for Paracetamol Diphenhydramine Chlorphenamine Tablets?
Standard commercial packaging for this line is Blister pack (PVC-Alu) or HDPE bottle, typically 10 or 20 tablets per blister strip, or 100 tablets per bottle. Alternative pack sizes are produced to your specification and are supported by the corresponding stability data.
What documentation comes with a shipment of Paracetamol Diphenhydramine Chlorphenamine Tablets?
The documentation set for every shipment includes the certificate of analysis (description, identification, assay, related substances), stability data for the marketed pack, and the site GMP certificate. Shelf life: 36 months.
Does the batch documentation for Paracetamol Diphenhydramine Chlorphenamine Tablets support a registration filing?
The documentation set for every shipment includes the certificate of analysis (description, identification, assay, related substances), stability data for the marketed pack, and the site GMP certificate. Shelf life: 36 months. The full CTD dossier and the authority assessment file are supplied as part of a registration order; routine shipments carry the COA and stability data only.
Can you supply sustained-release or combination analgesics?
Yes — including compound presentations and sustained-release forms. Confirm the specific combination against your national registration before ordering.
Which strengths of paracetamol oral liquid should we order?
The WHO Model List notes that offering both 120 mg/5 mL and 125 mg/5 mL on one market causes prescribing and dispensing confusion. We recommend selecting one strength per market and will supply accordingly.
Products Commonly Ordered with Paracetamol Diphenhydramine Chlorphenamine Tablets
- Aspirin 300mg Tablets — 300mg
- Ibuprofen 100mg Tablets — 100mg
- Methamizole 500mg Tablets — 500mg
- Paracetamol 500mg Tablets — 500mg
- Paracetamol Effervescent 500mg Tablets — 500mg
- Ibuprofen Suppository 50mg — 50mg
Browse the full Analgesics & NSAIDs range; all Tablets; the complete product catalogue.
Request a Quotation for Paracetamol Diphenhydramine Chlorphenamine Tablets
Tell us the monograph, pack size and quantity required for Paracetamol Diphenhydramine Chlorphenamine Tablets 500mg, together with the destination market, and the quotation will state lead time and the documents that ship with the batch. Samples for registration can be added to the same order.
Sources & Regulatory Notes
- WHO Model List of Essential Medicines, 24th List (2025) — report of the 25th WHO Expert Committee (TRS 1064)
- MSF Medical Guidelines — Malaria (Chapter 4.3, Parasitic infections)
Reference information only. The published guidance summarised on this page is quoted for professional and regulatory-context purposes and does not constitute medical advice, a prescribing recommendation or a promotion of any product for a particular indication. Prescribing decisions must follow the approved product information and national treatment guidelines in the market of use.
